Cas:1005582-20-6 2-(4-methylpyrazol-1-yl)propanoic acid manufacturer & supplier

Chemical Name:2-(4-methylpyrazol-1-yl)propanoic acid

CAS.NO:1005582-20-6

Synonyms:2-(4-methyl-1H-pyrazol-1-yl)propanoic acid;2-(2-PYRROLYL)ETHYLAMINE HYDROCHLORIDE;2-(4-Methyl-pyrazol-1-yl)-propionic acid;2-(4-methylpyrazolyl)propanoic acid

Molecular Formula:C₇H₁₀N₂O₂

Molecular Weight:154.16600

HS Code:2933199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:55.12000

Exact Mass:154.07400

LogP:0.83710

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(4-methyl-1H-pyrazol-1-yl)propanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-methylpyrazolyl)propanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-PYRROLYL)ETHYLAMINE HYDROCHLORIDE Use and application,2-(4-methylpyrazolyl)propanoic acid technical grade,usp/ep/jp grade.

Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia. 2-(4-methylpyrazol-1-yl)propanoic acid manufacturer Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 2-(4-methylpyrazol-1-yl)propanoic acid supplier Also, states with higher obesity rates also tend to have higher rates of food insecurity, which means lower incomes in general,” she noted. “Bariatric surgery is an expensive proposition, especially if one does not have good insurance coverage for it. 2-(4-methylpyrazol-1-yl)propanoic acid vendor Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 2-(4-methylpyrazol-1-yl)propanoic acid factory China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.